Circulating Tumor Dna (ctdna) - Pharma

Relevant Publications

Exploring the biology of ctDNA release in colorectal cancer.

Issue Release: 2024

Circulating cell-free (cf)DNA analysis: Current technologies and applications in gynecologic cancer.

Issue Release: 2024

Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers.

Issue Release: 2024

Plasma circulating tumor DNA unveils the efficacy of PD-1 inhibitors and chemotherapy in advanced gastric cancer.

Issue Release: 2024

Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer.

Issue Release: 2024

Hodgkin lymphoma and liquid biopsy: a story to be told.

Issue Release: 2024

PROMER technology: A new real-time PCR tool enabling multiplex detection of point mutation with high specificity and sensitivity.

Issue Release: 2024

Excitation/emission-enhanced heterostructure photonic crystal array synergizing with \"DD-A\" FRET entropy-driven circuit for high-resolution and ultrasensitive analysis of ctDNA.

Issue Release: 2024

Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatment.

Issue Release: 2024

Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.

Issue Release: 2024

Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers.

Issue Release: 2024

Potential predictors of the pathologic response after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a narrative review.

Issue Release: 2024

Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression.

Issue Release: 2024

Emerging Strategies in Adjuvant Immunotherapy: A Comparative Review of Bladder Cancer and Renal Cell Carcinoma Treatments.

Issue Release: 2024

Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma.

Issue Release: 2024

Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma.

Issue Release: 2024

Strategic approaches in oral squamous cell carcinoma diagnostics using liquid biopsy.

Issue Release: 2024

Dynamic changes in tumor profiling reveal intra- and inter-tumoral heterogeneity focused on an uncharacterized HER2 mutation: a case report of a young breast cancer patient.

Issue Release: 2024

A quadratic isothermal amplification fluorescent biosensor without intermediate purification for ultrasensitive detection of circulating tumor DNA.

Issue Release: 2024

ATR inhibitor, camonsertib, dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).

Issue Release: 2024

Why is Regulatory Approval Important?

What are the Key Challenges?

How Long Does the Approval Process Take?

What Are Clinical Trials?

What Are the Challenges of Clinical Trials?

How are New Drugs Discovered?

What Causes Adverse Drug Events?

What is Geriatric Care in Pharma?

What are the Implications for Pharma Companies?

How Can Pharmacists Contribute to Transitional Care?

Partnered Content Networks

Relevant Topics